GlassScriptPhysician profile
Christy Chai
NPI 1326117813
$7,142.13
in general payments reported to CMS, 2019-2025
12 companies · $4,115 in 2025
The $4,115 reported for 2025 was more than what 89% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $354 · 2021: $618 · 2022: $348 · 2023: $799 · 2024: $306 · 2025: $4,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $856 · Travel and Lodging: $295 · Education: $68.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $856.01 |
| Travel and Lodging | $295.37 |
| Education | $68.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,955.37 | 2019-2025 | |
| Stryker Corporation | $756.85 | 2019-2023 | 1688 |
| Endomagnetics LTD | $608.66 | 2021-2023 | Magtrace, Magseed |
| Imbed Biosciences INC. | $221.21 | 2023 | |
| Davol INC. | $154.11 | 2022 | |
| Abbvie INC. | $114.04 | 2020 | |
| Tela Bio, INC. | $90.13 | 2019-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Arthrex, INC. | $64.28 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $54.23 | 2022 | |
| W. L. Gore & Associates, INC. | $52.33 | 2021 | |
| Smith+Nephew, INC. | $47.63 | 2019-2025 | Renasys Touch |
| Aroa Biosurgery Incorporated | $23.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Chai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.